Sleepless latency of human cytomegalovirus

Medical Microbiology and Immunology

Volumn 204, Issue 3, 2015, Pages 421-429

  Poole, Emma ^a   Sinclair, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell survival; Human cytomegalovirus; Latency

Indexed keywords

CD34 ANTIGEN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 10; LACMVIL 10 PROTEIN; MICRORNA; MICRORNA 92A; PROTEIN BCL 2; PROTEIN P53; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYTOKINE;

CELL FUNCTION; CELL SURVIVAL; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; HOST CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; IMMUNOSURVEILLANCE; LATENT VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; STEM CELL; TRANSCRIPTION REGULATION; UL111A GENE; UPREGULATION; VIRUS GENE; VIRUS LATENCY; VIRUS REACTIVATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MICRORNAS; VIRUS LATENCY;

EID: 84929958692     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-015-0401-6     Document Type: Review

References (85)

1. Goodrum FD, Jordan CT, High K, Shenk T (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci USA 99(25):16255–16260
2. Hargett D, Shenk TE (2011) Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci USA 107(46):20039–20044
3. Rossetto CC, Tarrant-Elorza M, Pari GS (2013) Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells. PLoS Pathog 9(5):e1003366
4. Poole E, Wills M, Sinclair J (2014) Human cytomegalovirus latency: targeting differences in the latently infected cell with a view to clearing latent infection. New J Sci 2014:10
5. Sinclair J, Poole E (2014) Human cytomegalovirus latency and reactivation in and beyond the myeloid lineage. Future Virol 6:7
6. Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71(4):2980–2987
7. Seckert CK, Griessl M, Buttner JK, Scheller S, Simon CO, Kropp KA, Renzaho A, Kuhnapfel B, Grzimek NK, Reddehase MJ (2012) Viral latency drives ‘memory inflation’: a unifying hypothesis linking two hallmarks of cytomegalovirus infection. Med Microbiol Immunol 201(4):551–566. doi:10.1007/s00430-012-0273-y
8. Murphy JCFW, Verdin E, Sinclair JH (2002) Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J 21:1112–1120
9. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102(11):4140–4145
10. Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87(Pt 7):1763–1779
11. Reeves M, Murphy J, Greaves R, Fairley J, Brehm A, Sinclair J (2006) Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J Virol 80(20):9998–10009
12. Groves IJ, Reeves MB, Sinclair JH (2009) Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic ‘pre-immediate-early’ repression of viral gene expression mediated by histone post-translational modification. J Gen Virol 90(Pt 10):2364–2374
13. Reeves MB, Sinclair JH (2013) Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol 87(19):10660–10667. doi:10.1128/JVI.01539-13
14. Poole E, Juss JK, Krishna B, Herre J, Chilvers ER, Sinclair J (2014) Alveolar macrophages isolated directly from HCMV seropositive individuals are sites of HCMV reactivation in vivo. J Infect Dis. doi:10.1093/infdis/jiu837
15. Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J (2009) Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J Virol 83(8):3581–3590
16. Rossini G, Cerboni C, Santoni A, Landini MP, Landolfo S, Gatti D, Gribaudo G, Varani S (2012) Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm 2012:607276. doi:10.1155/2012/607276
17. Poole E, Bain M, Teague L, Takei Y, Laskey R, Sinclair J (2012) The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus. PLoS One 7(10):e45686. doi:10.1371/journal.pone.0045686
18. Braun TE, Poole E, Sinclair J (2012) Depletion of cellular pre-replication complex factors results in increased human cytomegalovirus DNA replication. PLoS One 7(5):e36057. doi:10.1371/journal.pone.0036057
19. Murphy EA, Streblow DN, Nelson JA, Stinski MF (2000) The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol 74(15):7108–7118
20. Kalejta RF (2004) Human cytomegalovirus pp71: a new viral tool to probe the mechanisms of cell cycle progression and oncogenesis controlled by the retinoblastoma family of tumor suppressors. J Cell Biochem 93(1):37–45
21. Wright E, Bain M, Teague L, Murphy J, Sinclair J (2005) Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells. J Gen Virol 86(Pt 3):535–544
22. Poole E, King C, Sinclair J, Alcami A (2006) The UL144 gene product of human cytomegalovirus activates NF-kB via a TRAF6-dependent mechanism. EMBO J 25:4390–4399
23. Poole E, Atkins E, Nakayama T, Yoshie O, Groves I, Alcami A, Sinclair J (2008) NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. J Virol 82(9):4250–4256
24. Miller-Kittrell M, Sparer TE (2009) Feeling manipulated: cytomegalovirus immune manipulation. Virol J 6:4. doi:10.1186/1743-422X-6-4
25. Abraham CG, Kulesza CA (2013) Polycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models. J Virol 87(24):13193–13205
26. Salvant BS, Fortunato EA, Spector DH (1998) Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 72(5):3729–3741
27. Chaumorcel M, Lussignol M, Mouna L, Cavignac Y, Fahie K, Cotte-Laffitte J, Geballe A, Brune W, Beau I, Codogno P, Esclatine A (2012) The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1. J Virol 86(5):2571–2584. doi:10.1128/JVI.05746-11
28. Marshall EE, Bierle CJ, Brune W, Geballe AP (2009) Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J Virol 83(9):4112–4120. doi:10.1128/JVI.02489-08
29. Lang D, Gebert S, Arlt H, Stamminger T (1995) Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol 69:6030–6037
30. Browne EPST (2003) Evaluation of the host transcriptional response to human cytomegalovirus infection. Proc Natl Acad Sci USA 100:11439–11444
31. Poole E, McGregor Dallas SR, Colston J, Joseph RS, Sinclair J (2011) Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34 progenitors. J Gen Virol 92(Pt 7):1539–1549
32. Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH (2012) Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc Natl Acad Sci USA 109(36):14538–14543
33. Mason GM, Jackson S, Okecha G, Poole E, Sissons JG, Sinclair J, Wills MR (2013) Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T Cells. PLoS Pathog 9(10):e1003635
34. Poole E, Walther A, Raven K, Benedict CA, Mason GM, Sinclair J (2013) The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner. J Virol 87(8):4261–4271
35. Weekes MP, Tan SY, Poole E, Talbot S, Antrobus R, Smith DL, Montag C, Gygi SP, Sinclair JH, Lehner PJ (2013) Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science 340(6129):199–202
36. Wills MR, Poole E, Lau B, Krishna B, Sinclair JH (2014) The immunology of human cytomegalovirus latency: Could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol. doi:10.1038/cmi.2014.75
37. Slobedman B, Cheung AK (2008) Microarrays for the study of viral gene expression during human cytomegalovirus latent infection. Methods Mol Med 141:153–175
38. Cheung AK, Abendroth A, Cunningham AL, Slobedman B (2006) Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108(12):3691–3699
39. Stern JL, Slobedman B (2008) Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1. J Immunol 180(10):6577–6585
40. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843–854
41. Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB, Bartel DP (2003) The microRNAs of Caenorhabditis elegans. Genes Dev 17(8):991–1008. doi:10.1101/gad.1074403
42. Friedlander MR, Lizano E, Houben AJ, Bezdan D, Banez-Coronel M, Kudla G, Mateu-Huertas E, Kagerbauer B, Gonzalez J, Chen KC, LeProust EM, Marti E, Estivill X (2014) Evidence for the biogenesis of more than 1000 novel human microRNAs. Genome Biol 15(4):R57. doi:10.1186/gb-2014-15-4-r57
43. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP (2010) Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 24(10):992–1009. doi:10.1101/gad.1884710
44. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901–906. doi:10.1038/35002607
45. Brennecke J, Cohen SM (2003) Towards a complete description of the microRNA complement of animal genomes. Genome Biol 4(9):228. doi:10.1186/gb-2003-4-9-228
46. Xu P, Vernooy SY, Guo M, Hay BA (2003) The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13(9):790–795
47. Bhushan R, Grunhagen J, Becker J, Robinson PN, Ott CE, Knaus P (2013) miR-181a promotes osteoblastic differentiation through repression of TGF-beta signaling molecules. Int J Biochem Cell Biol 45(3):696–705. doi:10.1016/j.biocel.2012.12.008
48. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590–610. doi:10.1016/j.molonc.2012.09.006
49. Koga Y, Yasunaga M, Takahashi A, Kuroda J, Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H, Matsumura Y (2010) MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res 3(11):1435–1442. doi:10.1158/1940-6207.CAPR-10-0036
50. Lawrie CH, Ballabio E, Dyar OJ, Jones M, Ventura R, Chi J, Tramonti D, Gooding S, Boultwood J, Wainscoat JS, Hatton CS, Schuh A (2009) MicroRNA expression in chronic lymphocytic leukaemia. Br J Haematol 147(3):398–402. doi:10.1111/j.1365-2141.2009.07857.x
51. Iorio MV, Croce CM (2012) microRNA involvement in human cancer. Carcinogenesis 33(6):1126–1133. doi:10.1093/carcin/bgs140
52. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T (2004) Identification of virus-encoded microRNAs. Science 304(5671):734–736
53. Bennasser Y, Le SY, Yeung ML, Jeang KT (2006) MicroRNAs in human immunodeficiency virus-1 infection. Methods Mol Biol 342:241–253
54. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315(5818):1579–1582
55. Wang FZ, Weber F, Croce C, Liu CG, Liao X, Pellett PE (2008) Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 82(18):9065–9074
56. Fannin Rider PJ, Dunn W, Yang E, Liu F (2008) Human cytomegalovirus microRNAs. Curr Top Microbiol Immunol 325:21–39
57. Pan X, Minegishi N, Harigae H, Yamagiwa H, Minegishi M, Akine Y, Yamamoto M (2000) Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem 127(1):105–112
58. Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118(10):2653–2655. doi:10.1182/blood-2011-05-356352
59. Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R, Finke J (1996) Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood 88(7):2549–2558
60. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, Kok CH, Gagliardi L, Friend KL, Ekert PG, Butcher CM, Brown AL, Lewis ID, To LB, Timms AE, Storek J, Moore S, Altree M, Escher R, Bardy PG, Suthers GK, D’Andrea RJ, Horwitz MS, Scott HS (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43(10):1012–1017. doi:10.1038/ng.913
61. Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesu G, De Maria R, Stassi G (2006) Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res 66(3):1491–1499. doi:10.1158/0008-5472.CAN-05-2514
62. Zorzi E, Bonvini P (2011) Inducible hsp70 in the regulation of cancer cell survival: analysis of chaperone induction, expression and activity. Cancers 3(4):3921–3956. doi:10.3390/cancers3043921
63. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, Massie B (2000) The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 20(19):7146–7159
64. Sabirzhanov B, Stoica BA, Hanscom M, Piao CS, Faden AI (2012) Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis. J Neurochem 123(4):542–554. doi:10.1111/j.1471-4159.2012.07927.x
65. Stankiewicz AR, Lachapelle G, Foo CP, Radicioni SM, Mosser DD (2005) Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem 280(46):38729–38739. doi:10.1074/jbc.M509497200
66. Basu A, Haldar S (1998) The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 4(12):1099–1109
67. Liu M, Aneja R, Liu C, Sun L, Gao J, Wang H, Dong JT, Sarli V, Giannis A, Joshi HC, Zhou J (2006) Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells. J Biol Chem 281(26):18090–18097. doi:10.1074/jbc.M601324200
68. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A (2009) Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 83(19):9618–9629. doi:10.1128/JVI.01098-09
69. Jenkins C, Abendroth A, Slobedman B (2004) A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78(3):1440–1447
70. Jenkins C, Garcia W, Abendroth A, Slobedman B (2008) Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology 370(2):285–294. doi:10.1016/j.virol.2007.09.002
71. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 97(4):1695–1700
72. Ouyang P, Rakus K, van Beurden SJ, Westphal AH, Davison AJ, Gatherer D, Vanderplasschen AF (2014) IL-10 encoded by viruses: a remarkable example of independent acquisition of a cellular gene by viruses and its subsequent evolution in the viral genome. J Gen Virol 95(Pt 2):245–262. doi:10.1099/vir.0.058966-0
73. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt RM (1996) IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 394(3):365–370
74. Yu H, Lee H, Herrmann A, Buettner R, Jove R (2014) Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14(11):736–746. doi:10.1038/nrc3818
75. Nachtwey J, Spencer JV (2008) HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB. Viral Immunol 21(4):477–482
76. Spencer JV, Cadaoas J, Castillo PR, Saini V, Slobedman B (2008) Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 374(1):164–169
77. Hedrich CM, Bream JH (2010) Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 47(1–3):185–206. doi:10.1007/s12026-009-8150-5
78. Chang WL, Barry PA (2010) Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc Natl Acad Sci USA 107(52):22647–22652
79. Poole E, Avdic S, Hodkinson J, Jackson S, Wills M, Slobedman B, Sinclair J (2014) Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. J Virol 88(24):13947–13955. doi:10.1128/JVI.02424-14
80. Vicente C, Conchillo A, Garcia-Sanchez MA, Odero MD (2011) The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 82(1):1–17
81. Kaufmann T, Strasser A, Jost PJ (2012) Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ 19(1):42–50. doi:10.1038/cdd.2011.121
82. Lavrik IN (2014) Systems biology of death receptor networks: live and let die. Cell Death Dis 5:e1259. doi:10.1038/cddis.2014.160
83. Galluzzi L, Kepp O, Kroemer G (2012) Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 13(12):780–788. doi:10.1038/nrm3479
84. Ilmarinen P, Moilanen E, Kankaanranta H (2014) Mitochondria in the center of human eosinophil apoptosis and survival. Int J Mol Sci 15(3):3952–3969. doi:10.3390/ijms15033952
85. Reeves M, Woodhall D, Compton T, Sinclair J (2010) Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol 84(14):7185–7194